Yungjin Pharm. Co., Ltd. (YUNGJIN PHARM) aksje
003520.KS
Stengt₩1,267.00-3.00 (-0.24%)
Laster graf...
YUNGJIN PHARM
Market Cap
$231,724,728,320
Åpning1,270.00
Høy1,295.00
Lav1,236.00
Volum347.57k
P/EN/A
Markedsverdi231.72B
52-ukers høy2,450.00
52-ukers lav1,203.00
Gj.sn. volum417.69k
UtbytteN/A
Beta0.71
EPSN/A
Om Yungjin Pharm. Co., Ltd. (YUNGJIN PHARM) aksje
Yungjin Pharm. Co., Ltd. operates as a pharmaceutical company in South Korea and internationally. The company offers cephalosporin antibiotic, antipsychotic, cardiovascular, gastrointestinal, metabolic, neuropsychiatry, respiratory, infectious, anti-inflammatory and analgesics, nutritional supplement, and urology products. It also provides vitamins, minerals, and other products; and APIs. The company was founded in 1952 and is headquartered in Seoul, South Korea. Yungjin Pharm. Co., Ltd. operates as a subsidiary of KT&G Corporation.
Selskapsinformasjon
Børs: KSE (KSC)
Sektor: Sundhed
Industri: Lægemiddelproducenter – Special og generisk
Adresse:
Jamsil Company Building
05510 Seoul, South Korea
05510 Seoul, South Korea
Telefon: + 82 2 2041 8200
Nettside: https://www.yungjin.co.kr
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Laveste kursmål
Gjennomsnittlig kursmål
Median kursmål
Høyeste kursmål